Ardelyx (ARDX) EBITDA Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,003.00 |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 19,505.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,505.00 |
| Dec 31, 2025 | -2,461.00 |
| Sep 30, 2025 | 43,551.00 |
| Jun 30, 2025 | 104,767.00 |
| Mar 31, 2025 | 596,003.00 |
| Dec 31, 2024 | 352,605.00 |
| Sep 30, 2024 | 371,541.00 |
| Jun 30, 2024 | 341,824.00 |
| Mar 31, 2024 | 44,562.00 |
| Dec 31, 2023 | 151,886.00 |
| Sep 30, 2023 | 68,759.00 |
| Jun 30, 2023 | 126,208.00 |
| Mar 31, 2023 | 161,452.00 |
| Dec 31, 2022 | 90,319.00 |
| Sep 30, 2022 | 32,240.00 |
| Jun 30, 2022 | 14.04 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 7.07 Mn |
| Mar 31, 2021 | 23,171.00 |
| Jun 30, 2018 | -7.42 Mn |
| Mar 31, 2018 | -67,615.00 |